EUR 3.55
(-2.74%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -2.55 Million EUR | -159.27% |
2022 | 24.42 Million EUR | 19.53% |
2021 | 20.43 Million EUR | 53.11% |
2020 | 13.34 Million EUR | 50.8% |
2019 | 8.84 Million EUR | 42.5% |
2018 | 6.2 Million EUR | -17.57% |
2017 | 7.53 Million EUR | 20.61% |
2016 | 6.24 Million EUR | 63.61% |
2015 | 3.81 Million EUR | 442.03% |
2014 | -1.11 Million EUR | -197.75% |
2013 | 1.14 Million EUR | 34.87% |
2012 | 846.5 Thousand EUR | 172.35% |
2011 | -1.17 Million EUR | -759.27% |
2010 | -136.17 Thousand EUR | 82.27% |
2009 | -768.13 Thousand EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -12.71 Million EUR | 0.0% |
2023 Q2 | -7.2 Million EUR | 0.0% |
2023 Q4 | -343 Thousand EUR | 0.0% |
2023 FY | -14.47 Million EUR | -159.27% |
2022 Q4 | -8.59 Million EUR | 0.0% |
2022 FY | 24.42 Million EUR | 19.53% |
2022 Q2 | -7.67 Million EUR | 0.0% |
2021 Q4 | -5.09 Million EUR | 0.0% |
2021 FY | 20.43 Million EUR | 53.11% |
2021 Q2 | -2.34 Million EUR | 0.0% |
2020 Q2 | -2.8 Million EUR | 0.0% |
2020 Q4 | -2.69 Million EUR | 0.0% |
2020 FY | 13.34 Million EUR | 50.8% |
2019 Q2 | -188 Thousand EUR | 0.0% |
2019 FY | 8.84 Million EUR | 42.5% |
2019 Q4 | -1.9 Million EUR | 0.0% |
2018 Q4 | -1.07 Million EUR | 0.0% |
2018 FY | 6.2 Million EUR | -17.57% |
2018 Q2 | -3.28 Million EUR | 0.0% |
2017 FY | 7.53 Million EUR | 20.61% |
2017 Q4 | -3.64 Million EUR | 0.0% |
2017 Q2 | -3.86 Million EUR | 0.0% |
2016 FY | 6.24 Million EUR | 63.61% |
2016 Q2 | -997 Thousand EUR | 0.0% |
2016 Q4 | -1.58 Million EUR | 0.0% |
2015 Q2 | -1.24 Million EUR | 0.0% |
2015 FY | 3.81 Million EUR | 442.03% |
2015 Q4 | -689 Thousand EUR | 0.0% |
2014 FY | -1.11 Million EUR | -197.75% |
2014 Q4 | -1.14 Million EUR | 0.0% |
2014 Q2 | -1.28 Million EUR | 0.0% |
2013 Q2 | -1.52 Million EUR | 0.0% |
2013 Q4 | -2.95 Million EUR | 0.0% |
2013 FY | 1.14 Million EUR | 34.87% |
2012 Q4 | - EUR | 0.0% |
2012 FY | 846.5 Thousand EUR | 172.35% |
2012 Q2 | - EUR | 0.0% |
2011 Q4 | - EUR | 0.0% |
2011 FY | -1.17 Million EUR | -759.27% |
2010 FY | -136.17 Thousand EUR | 82.27% |
2009 FY | -768.13 Thousand EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Affluent Medical SA | -1.2 Million EUR | -112.583% |
Bluelinea Société Anonyme | -3.84 Million EUR | 33.699% |
Carmat SA | -30.97 Million EUR | 91.763% |
Diagnostic Medical Systems S.A. | 15.84 Million EUR | 116.102% |
Euromedis Groupe | 3.57 Million EUR | 171.425% |
Eurobio Scientific Société anonyme | 53.96 Million EUR | 104.727% |
Ikonisys S.A. | 255.82 Thousand EUR | 1097.158% |
Implanet S.A. | 3.13 Million EUR | 181.45% |
SpineGuard SA | 3.37 Million EUR | 175.495% |
Theraclion SA | -1.08 Million EUR | -136.12% |
Euroapi S.A. | 164.6 Million EUR | 101.55% |
Guerbet SA | 197.14 Million EUR | 101.294% |
Ion Beam Applications SA | 134.44 Million EUR | 101.897% |
Koninklijke Philips N.V. | 7.44 Billion EUR | 100.034% |
Sequana Medical NV | 548.04 Thousand EUR | 565.469% |